ResMed Inc. (RMD)

Market Cap	20.09B
Revenue (ttm)	4.22B
Net Income (ttm)	897.56M
Shares Out	147.07M
EPS (ttm)	6.09
PE Ratio	22.43
Forward PE	19.40
Dividend	$1.92 (1.41%)
Ex-Dividend Date	Aug 16, 2023

Volume	1,293,558
Open	137.75
Previous Close	136.29
Day's Range	136.43 - 138.56
52-Week Range	136.22 - 243.52
Beta	0.52
Analysts	Buy
Price Target	224.75 (+64.52%)
Earnings Date	Oct 26, 2023

About RMD

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. It operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Jun 2, 1995
• Employees: 10,140
• Stock Exchange: NYSE
• Ticker Symbol: RMD

Financial Performance

In 2023, ResMed's revenue was $4.22 billion, an increase of 18.02% compared to the previous year's $3.58 billion. Earnings were $897.56 million, an increase of 15.15%.

Analyst Forecast

According to 8 analysts, the average rating for RMD stock is "Buy." The 12-month stock price forecast is $224.75, which is an increase of 64.52% from the latest price.

Price Target

$224.75

(64.52% upside)

Analyst Consensus: Buy